A2 Biotherapeutics
Manufacturing · 51-200 Employees
View Company Info for Free
Overview
Website
www.a2biotherapeutics.comRevenue
$8.4 MillionIndustry
ZI Rank: 1
About A2 Biotherapeutics
A2 Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is A2 Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if A2 Biotherapeutics had a recent Job posting/layoffs
A2 Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at A2 Biotherapeutics
Check if A2 Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on A2 Biotherapeutics recently announced quarterly report
Product Launch: Get notified when A2 Biotherapeutics launches new products
Check out if A2 Biotherapeutics is spiking on competitors!
Funding: Get notified immidiatlly once A2 Biotherapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding A2 Biotherapeutics
A2 Biotherapeutics focuses on advancing cancer treatment through innovative cell therapy, specifically targeting solid tumors with their proprietary Tmod platform. This technology enables precise differentiation between tumor and normal cells, overcoming the limitations of traditional therapies. The company is well-positioned to deliver a broad pip... Read More
